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Abstract
Objectives: To compare the different variations of sinus elevation techniques with osteotomes, to evaluate the 
increase in height achieved, and to quantify the osseointegration periods and the success rates for the implants 
placed. 
Study Design: A meta-analytic study with descriptive statistics was carried out on sinus elevations using oste-
otomes, analyzing a total of 11 articles published between the years 2003 and 2008. 
Results: Summers’ classic technique for performing sinus elevations with osteotomes differs from the current 
techniques being used with respect to the use of drills, the manner in which the sinus floor is fractured and how 
the sinus membrane is lifted, and especially on the type of graft used—the most current tendency being not to 
use a graft. The maximum gain in height is 4.62 mm, and the minimum gain in height is 2.07 mm, starting with a 
maximum residual bone height of 8.8 mm and a minimum of 4.1 mm. The osseointegration period is 4.9 months 
and the success rate is 95.5%.
Conclusions: Performing sinus elevations with osteotomes is a predictable technique that enables achieving an 
increase in bone height and successful results, similar to those of other techniques used, in the placement of im-
plants.
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Introduction
Today in dental implant surgery, we find ourselves with 
several challenges that we must resolve every day at the 
clinic. One of the most frequent challenges is atrophy of 
the posterior maxilla due to pneumatization factors (si-
nus growth and expansion), resorption due to prolonged 
edentulism and biological aging (a decrease in osteob-
last and osteoclast capacity, and a decrease in minerali-
zation and vascularization). Expansion of the maxillary 
sinus occurs in the inferior and lateral parts, and can 
even spread towards the lateral pyriform ridge of the 
nose, in the region of the canine eminence. As a result 
of all of these changes, there is a significant decrease in 
the height of the bone available in the posterior section 
of the upper arcade. Consequently, we often end up with 
a residual bone height of less than 10 mm between the 
alveolar ridge of the crest and the sinus floor.
In 1974, Tatum (1) developed a modified Caldwell Luc 
procedure for placing grafts in the maxillary sinus floor, 
which was presented in 1977 at the Annual Meeting of 
the Alabama Implant Study Group, in Birmingham. 
This sinus elevation technique continued to evolve un-
til a way was found in which implants could be placed 
simultaneously.
In the early 1990s, Summers developed a technique 
called bone-added osteotome sinus floor elevation (BA-
OS�E), in which the particles of material displaced the 
sinus membrane apically and thus enabled achieving 
an adequate height for the placement of the implants. 
This technique was proposed for a residual bone height 
(RBH) of 5-7 mm (2).
At the Consensus Conference on Maxillary Sinus El-
evation in 1996 (3), the members made the following 
recommendations which depend on the residual bone 
height (RBH):
• Category A (RBH ≥ 10 mm): classic implant procedure
• Category B (RBH ≥ 7-9 mm): osteotome technique 
with simultaneous placement of implants 
• Category C (RBH ≥ 4-� mm): maxillary sinus eleva-
tion with lateral access and bone graft and immediate or 
deferred placement of implants
• Category � (RBH ≥ 1-� mm): maxillary sinus eleva-
tion with lateral access and bone graft and deferred 
placement of implants
Material and Methods
We carried out a meta-analytic study based on the re-
sults obtained from a bibliographic search in PubMed 
on maxillary sinus elevations with osteotomes. The se-
lection criteria were as follows:
- Publication between the years 2004 and 2010
- Articles with patients on whom the maxillary sinus el-
evations were performed using the osteotome technique 
with simultaneous or deferred placement of implants, 
with no restriction as to the number of cases.
Articles which only explained the maxillary sinus eleva-
tion technique using osteotomes and which did not show 
results in patients, meta-analytic studies or reviews, as 
well as articles in which the technique was carried out 
on cadavers, were excluded. The eleven articles selected 
were used for making a descriptive statistical analysis 
of the following variables:
• Number and sex of the patients
• Implants: number, length, thickness and treatment of 
the surface
• Surgical technique: analyzing the procedure for using 
drills and osteotomes, the fracture of the maxillary si-
nus floor, the decision to use or not to use bone graft and 
the type of bone graft used, where applicable, the bone 
height and the height achieved after the elevation. With 
regard to the complications, we analyzed the perfora-
tion of the membrane and therapeutic approach in such 
a case, in addition to the occurrence of benign paroxys-
mal positional vertigo (BPPV).
• Period of osseointegration
• Implant survival rate
Results
We compiled a total of 1,219 patients, consisting of 287 
men and 386 women, whereas the sex was not speci-
fied for the remaining 54� patients. A total of 2,0�� im-
plants were placed in the patients. Given that it was not 
possible to obtain all of the parameters outlined in the 
descriptive statistical analysis in each one of the arti-
cles, we analyzed a variable sample according to each 
parameter to be studied (Table 1).
The surgical technique was studied on a sample of 1,251 
implants. In the majority of the literature, a combina-
tion of twist drills and used osteotomes up to 0.5-1.5 
mm from the maxillary sinus floor were used. In 4�% 
of the implants placed, the drilling was performed with-
out any type of irrigation. In 2.5% of the implants, no 
drilling was used for the ostectomy. The fracture of the 
maxillary sinus floor was performed with osteotomes. 
Bone grafts were used in 83.1% of the implants placed, 
whereas in the remaining implants placed, the maxil-
lary sinus elevation was carried out using osteotomes 
without any type of graft. In the implants placed using 
bone graft, it served as a cushioning for fracturing the 
maxillary sinus floor, reducing the risk of perforation 
of the sinus membrane. As for the type of bone graft 
used, bovine bone mixed with autogenous bone was 
used in 96.54% of the implants, whereas ceramic bone 
along with autogenous bone was used in 3.37% of the 
implants. In 0.1% of the cases, Demineralized �reeze-
Dried Bone Allograft (D�DBA) was used. The maxil-
lary sinus floor was fractured using osteotomes, adding 
bone graft in those cases where it was used, and using 
a surgical hammer to tap it lightly. In 11.11% of the im-
plants analyzed, a collagen sponge was added in addi-
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AUTHOR 
No. of 
Implants 
No. of 
Patients 
SURGICAL 
TECHNIQUE 
PERFORATI
ON OF 
MEMBRANE
RESIDUAL
VERTICAL
BONE 
HEIGHT 
HEALING 
PERIOD SURVIVAL RATE
BONE 
GRAFT 
BONE 
HEIGHT 
GAINED 
 TYPE OF 
IMPLANTS 
Toffler 
2004 
 
Implants:276 
Patients:167 
 
DRILLS+OSTEOT 
136 IMPLANTS 
WITH BONE 
GRAFT  
140 IMPLANTS 
WITH COLLAGEN 
SPONGE 
4.7% 
(+) 
COLLAGE
N 
SPONGE 
FROM 02 
(+) NO  
BONE 
 
3-10 mm 
 
5 months 
 
93.05% 
 
AUTOGENO
US BONE 
(Sect.-Tub.) 
(10 - 75%)+ 
BOVINE 
BONE 
 
2-7 mm 
3i, ASTRA, 
DENTSPLY® 
8.5-9-10-11-
11.5-13-15 mm 
 
Brägger et 
al. 
2004 
 
Implants:25 
Patients:19 
 
DRILLS+OSTEOT 
BOVINE 
+AUTOGENOUS 
BONE 
4% 
(+)  NO 
BOVINE 
BONE 
 
2.3-10.3 
mm 
 
6 months 
 
95.83% 
 
AUTOGENO
US BONE +  
BOVINE 
BONE 
 
M: 3.6±1.7 
mm 
D: 4±1.6 
mm 
ITI ® 
8-10 mm 
 
Leblebicioglu
et al. 
2005 
 
Implants: 75 
Patients: 40 
 
DRILLS+OSTEOT 
Fugazzotto Formula 
 
3.7% 
 
5.7-10.7 
mm 
 
6 months 
 
97.3% 
 
NO 
 
<9mm:3.9
±1.9mm 
>9mm:2.9
±1.2mm 
 
Ferrigno et 
al. 
2006 
 
Implants:588 
Patients:323 
DRILLS+OSTEOT 
+PROF 
INDICATOR  
AUTOGENOUS 
BONE 
Ļ FREQ. BOVINE 
BONE WITHOUT 
IRRIGATION 
2.2% 
(+) 
DEFERRE
D 
SURGERY 
FOR 3 
MONTHS 
 
 
6-9 mm 
 
91-95: 6 
months 
95: 4 
months 
 
90.08% 
 
AUTOGENO
US BONE + 
(Drills/Tub.) 
BOVINE 
BONE 
 
M:2.6±0.8 
mm 
D: 3.1±1 
mm 
 
ITI ® 
8-10-12 mm 
SLA, TPS 
Calvo et al. 
2006 
 
Implants: 48 
Patients:24 
 
DRILLS+OSTEOT 
AUTOGENOUS+B
OVINE BONE 
  5-13 mm 
 
6-7 months 
 
100% 
 
AUTOGENO
US BONE + 
BOVINE 
BONE 
 
6.75±1.25 
mm 
3i ® 
11.5-13 mm 
 
Stavropoulos 
et al. 
2006 
 
Implants:35 
Patients:26 
 
1st Sinus elevation 
with osteotomes+ 
Autogenous bone 
2nd Implant Surgery 
  2-9 mm 
 
Implants 
4.4±1.4 m 
PROT 
6±1.7m 
 
82.09% 
 
AUTOGENO
US BONE + 
(Synphysis) 
CERÁMIC 
BONE 
 
3i ® 
13 mm 
 
Diserens et 
al. 
2006 
 
Implants: 66 
Patients: 55 
 
DRILLS+OSTEOT 
BOVINE BONE 
 
 
 
Min. 4 mm 
 
6 months 
F.Healing 
98.5% 
F. Load 
100% 
AUTOGENO
US BONE + 
BOVINE 
BONE (60%) 
 
0.5-6 mm 
 
STRAUMANN 
6-8-10-12 mm 
 
Nedir et al. 
2006 
 
Implants: 25 
Patients: 17 
 
DRILLS+OSTEOT 
WITHOUT BONE 
 
16% 
(+): 
Implant 
length 
8-6 mm 
 
5.4±2.3 mm 
 
3-4 months 
 
100% 
 
NO 
 
2.5±1.2 
mm 
M: 2.4±1.3 
mm 
D: 2.6±0.9 
mm 
 
 
ITI ® 
6-8-10 mm 
 
Diss et al. 
2008 
 
Implants:35 
Patients:20 
 
3 MEMBRANES 
PERFORATION+O
STEOT 
 
6.5±1.7 mm 
 
1.5-3 
months 
 
97.1% 
 
NO 
 
3.2±1.5 
mm 
M: 3.5±1.4 
mm 
D: 2.9±1.6 
mm 
 
ASTRA ® 
8-9-11-13 mm 
 
Fermergard 
et al. 
2008 
 
Implants:53 
Patients:36 
 
DRILLS+ OSTEOT 
WITHOUT BONE 
  6.3±0.3 mm 
 
3-4  months 
 
96% 
 
NO 
 
4.4±0.2 
mm 
ASTRA ® 
9-11-13 mm 
 
Schmidlin  
et al. 
2008 
 
Implants:24 
Patients:24 
 
DRILLS+OSTEOT 
WITHOUT BONE 
 
8.3% 
 
5±1.5 mm 
 
6 months 
 
100% 
 
NO 
 
3.6±1.4 
mm 
 
STRAUMANN 
6-8-10 mm 
 
Table 1. Detail of data from the articles selected.
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tion to the osteotomes in order to soften the fracture 
of the sinus floor. The elevation of the sinus membrane 
was one of the most delicate parts of the technique and 
it was performed using osteotomes, with the bone graft 
itself, if used, or with the depth indicators. The average 
initial residual bone height was a minimum of 4.3 mm 
and a maximum of 8.8 mm. The average bone height 
achieved was a maximum of 5.55 mm and a minimum 
of 2.28 mm (�ig. 1).
With regard to the complications associated with this 
technique, we have described two complications in our 
analysis: the perforation of the Schneider membrane 
during elevation and the subsequent onset of Benign 
Paroxysmal Positional Vertigo (BPPV). The perforation 
of the sinus membrane can go undetected in some cases, 
given that there is not a direct view of the perforation. 
This complication was analyzed on a sample of 1,013 
dental implants and was observed to occur in an average 
of 6.5% of the cases. In the cases where perforation of 
the membrane was positive, no additional means were 
used in 9.7% of the cases; short implants (6.8 mm) were 
used in 2.5% of the cases; the surgery was deferred for 
3 months in 58% of the implants; collagen sponges were 
used in order to cover the perforation in 13.82% of the 
implants; and no type of bone graft was used in 16.28% 
of the implants. 
The second complication was the onset of BPPV af-
ter performing the maxillary sinus elevation with os-
teotomes. A sample of 813 implants was analyzed, in 
which the frequency of occurrence was 1.25%. A total of 
2,063 implants were placed. When analyzing the length 
of the implants, the size was not specified for 4�.2% of 
the sample.  Taking a sample of 1,110 implants, the dis-
tribution in terms of the length of the implant was as fol-
lows: 6 mm in 0.27% of the sample; 8-9 mm in 15.94% 
of the sample; 9-10 mm in 39.63% of the sample; 11-12 
mm in 31.08% of the sample; and more than 12 mm in 
13.06% of the sample. 
The average osseointegration period was calculated for 
a sample of 1,250 implants, obtaining an average of 4.8 
months. The waiting periods varied greatly and there was 
no consensus among the different authors. The shortest 
osseointegration periods, ranging from 1.5 to 3 months, 
were reported for 2.8% of the implants. In 6.24% of the 
cases, the waiting period was 3-4 months. The longest 
osseointegration period was 4 months, which was the 
reported for 36.56% of the implants. Exceeding these 
osseointegration times, a period of 5 months was re-
ported in 22.08% of the cases, and a period of 6 months 
in 25.68% of the cases. �or 6.64% of the implants, the 
waiting period ranged from 6 to 7 months.
The survival rate for implants placed using the max-
illary sinus elevation technique with osteotomes was 
calculated on a sample of 1,250 implants. Given that 
Fig. 1. Comparison of the initial residual vertical bone height in the different studies and the gain in height achieved after sinus elevation 
with osteotomes.
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the follow-up time varied in the studies analyzed, the 
survival rates that were obtained also varied depending 
on the length of the follow-up time: 98% at 6 months; 
94.1% at one year; 100% at 18 months; 97.3% at 25 
months; 93.5% at 28 months; and 90.80% at 12 years 
(�ig. 2). The success rate at 12 years was only calculated 
in one study, obtaining a 90.8% success rate. The crite-
ria used for calculating the survival rate in the studies 
were based on the implants that were functional and did 
not have any type of associated symptoms.
Discussion 
In accordance with the objectives outlined in our meta-
analytic study, we analyzed the variations in the surgi-
cal technique used for performing maxillary sinus el-
evations with osteotomes. 
Toffler (4) used drills and osteotomes up to 0.5-1.2 mm 
from the floor of the maxillary sinus. The procedure 
they used for fracturing the sinus floor evolved dur-
ing the course of their study. Initially, it was performed 
by filling the alveolus with bone graft and pushing it 
apically using an osteotome and a hammer. They later 
switched to the technique used by Cavicchia et al. (5), 
in which the maxillary sinus floor is perforated with 
the last osteotome. The integrity of the membrane was 
checked and a collagen sponge was placed apically, to 
which the bone graft was added. Leblebicioglu et al. (6) 
used the smallest diameter osteotome to fracture the si-
nus floor (7). Ferrigno et al. (8) used ostectomy drills 
without any type of irrigation, given that this enabled 
collecting the chips of autogenous bone from the drills 
in order to then use them to fill the bone graft. Stavro-
poulos et al. (9) used only osteotomes and a surgical 
hammer for preparing the ostectomy, without using any 
type of drill. They also performed the sinus elevation 
with osteotomes in the first surgery; and after a waiting 
period of 4-6 months, they performed a second surgery 
in order to place the implants.
With regard to the fracture of the maxillary sinus floor, 
there is a consensus among the authors studied, who 
perform it with osteotomes and a surgical hammer, ab-
sorbing the tapping with the bone graft in those cases 
where it is used. 
On analyzing the type of bone graft used, we observed 
Fig. 2. Survival rate of the studies, along with the different follow-up periods.
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how it was used in 83.1% of the implants, and we found 
that in 96.54% of these cases autogenous bone was 
mixed with bovine bone. Toffler (4) made the mixture in 
a proportion of 75/10% respectively, and they obtained 
it from the tuberosity or from the area behind the man-
dible. Brägger et al. (10) mixed the bovine bone with 
chips of autogenous bone obtained from the drilling, 
similar to that of �errigno et al. (8), who performed an 
ostectomy without irrigation; and Calvo-Guirado et al. 
(11), Diserens et al. (12) and Stavropoulos et al. (9) used 
a bone graft formed by the mixture of ceramic bone and 
autogenous bone derived from the mandibular symphy-
sis. The current tendency is to perform maxillary sinus 
elevations with osteotomes, without using any type of 
bone graft (6, 13-16).
The gain in height was analyzed on a sample of 1,215 
implants. The initial average of the residual bone was a 
minimum of 4.3 mm and a maximum of 8.8 mm. It must 
be noted here that there are authors who performed si-
nus elevations with osteotomes when the minimum re-
sidual height was less than 4 mm (4,10,12,13,16). The 
bone height achieved varied greatly among the different 
authors. The minimum average increase in height was 
2.28 mm, and the maximum was 5.55 mm. However, 
some authors achieved a maximum increase in height 
of more than 6 mm (4,11,12).
The complications analyzed were perforation of the si-
nus membrane and BPPV. Perforation of the sinus mem-
brane was analyzed on a sample of 1,013 implants, and 
occurred in 6.5% of the cases. When this was positive, 
authors such as Leblebicioglu et al. (6) and Schmidlin et 
al. (16) did not use any additional means.  On the other 
hand, �errigno et al. (8) preferred to defer the surgery by 
3 months. Nedir et al. (13) placed short implants measur-
ing 6-8 mm in the cases where the Schneider membrane 
had been perforated. Brägger et al. (10) avoided the use 
of bone graft in such situations. In the first years of his 
study, Toffler (4) placed a collagen sponge in the perfo-
ration and then inserted the bone graft and the implant. 
In recent years, however, similar to Brägger et al. (10), 
he did not use any type of bone graft in cases where the 
Schneider membrane had been perforated.  
The onset of BPPV was analyzed on a sample of 468 
patients and was found to occur in 2.13% of the cases. 
Its associated symptoms of vertigo accompanied by 
nystagmus have a varied etiology, which could be idi-
opathic or due to traffic accidents, ENT surgery, head 
injuries, surgeries with very long times in bed, vascular 
infections or disorders (17-20).  
The osseointegration period was analyzed on a sample 
of 1,250 implants, obtaining an average waiting peri-
od of 4.8 months for osseointegration. There are also 
studies that exceed this average, such as the studies by 
Toffler (4), with a waiting period of 5 months; those of 
Brägger et al. (10), Diserens et al. (12), Schmidlin et al. 
(16), and Leblebicioglu et al. (6),  with osseointegra-
tion periods of � months. In the first years of follow-up, 
�errigno et al. (8) reported waiting periods similar to 
those previously mentioned; although in recent years, 
the waiting period for osseointegration decreased to 4 
months, which is less than the average for this meta-
analysis. Calvo-Guirado et al. (11) also reported a longer 
osseointegration period than the average for our study: 
between �-7 months. These findings are similar to those 
of Stavropoulos et al. (9), who reported the longest os-
seointegration period: a full 7 months. Those who ob-
tained results below our average include the studies by 
Nedir et al. (13) and �ermergard et al. (15), with wait-
ing periods of 3-4 months. The study with the shortest 
osseointegration period is that of Diss et al. (14), who 
reported 1.5 to 3 months. This data is due to the use of 
PRF membranes (Platelet-rich fibrin).
The survival rate of the implants was evaluated for the 
combination of all of the cases, although we have speci-
fied the follow-up time for each study, given that these 
varied among the different authors. With a follow-up 
time of one year, we obtained an average success rate of 
94.1% (10,9,13,14,15). The majority of the survival rate 
values are above 90%. Of particular note are the studies 
by Schmidlin et al. (16), with a follow-up period of 18 
months and a survival rate of 100%; by Leblebibioglu 
et al. (6), with a follow-up period of 25 months and a 
survival rate of 97.0�%; and Toffler (4), with a follow-up 
period of 28 months and a survival rate of 93.05%. The 
study with the longest follow-up period, 12 years, was 
by �errigno et al. (8), with a survival rate of 90.08%. 
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